Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands: a retrospective cohort study

BACKGROUND: Vismodegib has been used for the treatment of locally advanced basal cell carcinoma (laBCC) and metastatic BCC (mBCC) since 2011. Most efficacy and safety data are provided by clinical trials. This study evaluates the effectiveness of vismodegib for the treatment of laBCC, mBCC and basal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Verkouteren, Babette J. A., Wakkee, Marlies, Reyners, An K. L., Nelemans, Patty, Aarts, Maureen J. B., Rácz, Emőke, Terra, Jorrit B., Devriese, Lot A., Alers, Robert-Jan, Kapiteijn, Ellen, van Doorn, Remco, Bekkenk, Marcel W., Reinders, Marie G.H.C., Mosterd, Klara
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8007568/
https://ncbi.nlm.nih.gov/pubmed/33462360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-01220-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados